Goldman Sachs Reengineers Nasdaq Yields with GPIQ
Yield is a drugWall Street is the dealer. Investors have spent the last three years chasing double-digit distributions while the…
Yield is a drugWall Street is the dealer. Investors have spent the last three years chasing double-digit distributions while the…
The Mathematics of FragilityMarkets are at record highs. The S&P 500 closed Friday at 6,816.89. Wall Street is celebrating a…
Wall Street is running out of decimalsThe numbers have become too heavy for the average brokerage account. On April 12,…
The ballots are counted. The results are deceptive. While the headline suggests a democratic pivot, the fiscal architecture remains shackled…
The New Architecture of Asian WealthThe old guard is not dying. It is upgrading. While retail investors sweat over the…
The Billionaire Bet on Ink and Paper The printing press is bleeding. David Hoffmann says he has the bandage. The…
Morgan Stanley is not a bank. It is a luxury brand with a brokerage license. Last night, as the sun…
Goldman Sachs Preps the Monday Morning Massacre The tweet arrived on a Friday. It signaled the end of the weekend…
The Institutional Pivot to Private MarketsThe 60/40 portfolio is dead. Larry Fink killed it. On April 10, BlackRock released a…
The Pitch is Green and the Balance Sheets are RedThe fan in the Kop thinks he is watching a game.…